Details of the Drug

General Information of Drug (ID: DMDPL7Y)

Drug Name

MenABCWY

Indication

Disease Entry	ICD 11	Status	REF
Meningococcal infection	1C1C	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01992536) Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03. U.S. National Institutes of Health.